Lafayette, NY, United States of America

Lawan Phusanti


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Princeton, NJ (US) (1997 - 2007)
  • Lafayette, NY (US) (1995 - 2009)

Company Filing History:


Years Active: 1995-2009

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Lawan Phusanti

Introduction

Lawan Phusanti is a notable inventor based in Lafayette, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of Type II diabetes. With a total of 4 patents to his name, Phusanti's work has the potential to impact many lives.

Latest Patents

Phusanti's latest patents include an innovative antidiabetic formulation and method. This pharmaceutical formulation is specifically designed for treating Type II diabetes. It features a combination of metformin and glipizide, carefully formulated to control moisture levels. This ensures that glipizide does not hydrolyze while allowing metformin to remain compressible when necessary. Additionally, a method for treating diabetes using this formulation is also provided.

Career Highlights

Lawan Phusanti is currently employed at Bristol-Myers Squibb Company, where he continues to develop groundbreaking pharmaceutical solutions. His expertise in formulating effective treatments for diabetes showcases his commitment to improving patient outcomes.

Collaborations

Phusanti has collaborated with esteemed colleagues such as Danping Li and Divyakant S Desai. These partnerships have further enhanced his research and development efforts in the pharmaceutical industry.

Conclusion

Lawan Phusanti's contributions to diabetes treatment through his innovative patents highlight his role as a significant inventor in the pharmaceutical field. His work not only advances medical science but also offers hope to those affected by Type II diabetes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…